Skip to main content
. 2017 Apr 6;8(28):45249–45258. doi: 10.18632/oncotarget.16902

Table 1. Correlations between p-ERK and ERK expression and various clinicopathologic parameters in ESCC.

Parameter Case NO. low/high expression
p-ERK ERK
Age ≤ 57 66 38/28 20/46
> 58 65 27/38 20/45
Gender Male 98 48/50 31/67
Female 33 17/16 9/24
Tumor site Upper 13 4/9 3/10
Middle 104 54/50 33/71
Lower 14 7/7 4/10
Differentiation Poor 12 4/8*0.04 2/10*0.012
Intermediate 75 37/38 20/55
Well 44 30/14 18/16
Tumor size > 5 cm 82 40/42 25/57
< 5 cm 49 25/24 15/34
Depth of invasion T1–T2 103 55/48 28/75
T3–T4 28 10/18 12/16
Lymph metastasis Yes 68 31/37 18/50
No 63 34/29 22/41
Clinical Stage 1 6 4/2*0.02 5/1*0.031
2 55 35/20 17/38
3 64 25/39 17/47
4 6 1/5 1/5

* p < 0.05.